Literature DB >> 15645261

Mitochondrial damage and histotoxic hypoxia: a pathway of tissue injury in inflammatory brain disease?

F Aboul-Enein1, H Lassmann.   

Abstract

The immunological mechanisms leading to tissue damage in inflammatory brain diseases are heterogeneous and complex. They may involve direct cytotoxicity of T lymphocytes, specific antibodies and activated effector cells, such as macrophages and microglia. Here we describe that in certain inflammatory brain lesions a pattern of tissue injury is present, which closely reflects that found in hypoxic conditions of the central nervous system. Certain inflammatory mediators, in particular reactive oxygen and nitrogen species, are able to mediate mitochondrial dysfunction, and we suggest that these inflammatory mediators, when excessively liberated, can result in a state of histotoxic hypoxia. This mechanism may play a major role in multiple sclerosis, not only explaining the lesions formed in a subtype of patients with acute and relapsing course, but also being involved in the formation of diffuse "neurodegenerative" lesions in chronic progressive forms of the disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15645261     DOI: 10.1007/s00401-004-0954-8

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  28 in total

1.  Comparative gene expression analysis in mouse models for multiple sclerosis, Alzheimer's disease and stroke for identifying commonly regulated and disease-specific gene changes.

Authors:  Vivian Tseveleki; Renee Rubio; Sotiris-Spyros Vamvakas; Joseph White; Era Taoufik; Edwige Petit; John Quackenbush; Lesley Probert
Journal:  Genomics       Date:  2010-05-07       Impact factor: 5.736

Review 2.  Nitric oxide and multiple sclerosis.

Authors:  Juan Manuel Encinas; Louis Manganas; Grigori Enikolopov
Journal:  Curr Neurol Neurosci Rep       Date:  2005-05       Impact factor: 5.081

Review 3.  Role of mitochondria in multiple sclerosis.

Authors:  Bernadette Kalman
Journal:  Curr Neurol Neurosci Rep       Date:  2006-05       Impact factor: 5.081

4.  CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis.

Authors:  LiPing Liu; Abdelmadjid Belkadi; Lindsey Darnall; Taofang Hu; Caitlin Drescher; Anne C Cotleur; Dolly Padovani-Claudio; Tao He; Karen Choi; Thomas E Lane; Robert H Miller; Richard M Ransohoff
Journal:  Nat Neurosci       Date:  2010-02-14       Impact factor: 24.884

Review 5.  Hemoglobins as new players in multiple sclerosis: metabolic and immune aspects.

Authors:  Meric A Altinoz; Emin M Ozcan; Bahri Ince; Sinan Guloksuz
Journal:  Metab Brain Dis       Date:  2016-05-28       Impact factor: 3.584

6.  Characterizing brain oxygen metabolism in patients with multiple sclerosis with T2-relaxation-under-spin-tagging MRI.

Authors:  Yulin Ge; Zhongwei Zhang; Hanzhang Lu; Lin Tang; Hina Jaggi; Joseph Herbert; James S Babb; Henry Rusinek; Robert I Grossman
Journal:  J Cereb Blood Flow Metab       Date:  2012-01-18       Impact factor: 6.200

7.  Lack of mitochondrial DNA deletions in lesions of multiple sclerosis.

Authors:  Andrei Blokhin; Tamara Vyshkina; Samuel Komoly; Bernadette Kalman
Journal:  Neuromolecular Med       Date:  2008       Impact factor: 3.843

8.  Reduced NAA-levels in the NAWM of patients with MS is a feature of progression. A study with quantitative magnetic resonance spectroscopy at 3 Tesla.

Authors:  Fahmy Aboul-Enein; Martin Krssák; Romana Höftberger; Daniela Prayer; Wolfgang Kristoferitsch
Journal:  PLoS One       Date:  2010-07-20       Impact factor: 3.240

Review 9.  Pathology of multiple sclerosis: where do we stand?

Authors:  Bogdan F Gh Popescu; Istvan Pirko; Claudia F Lucchinetti
Journal:  Continuum (Minneap Minn)       Date:  2013-08

10.  Spinal cord lesions in patients with neuromyelitis optica: a retrospective long-term MRI follow-up study.

Authors:  Wolfgang Krampla; Fahmy Aboul-Enein; Julia Jecel; Wilfried Lang; Elisabeth Fertl; Walter Hruby; Wolfgang Kristoferitsch
Journal:  Eur Radiol       Date:  2009-05-05       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.